TWO SIGMA INVESTMENTS, LP - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 114 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q3 2023$777,053
+0.7%
518,035
+6.7%
0.00%0.0%
Q2 2023$771,691
+73.2%
485,340
-21.9%
0.00%
+100.0%
Q1 2023$445,593
+8.7%
621,122
-12.2%
0.00%0.0%
Q4 2022$410,081
-58.8%
707,647
-32.5%
0.00%
-66.7%
Q3 2022$996,000
-28.7%
1,048,063
-10.0%
0.00%
-40.0%
Q2 2022$1,397,000
-32.0%
1,164,562
-25.8%
0.01%
-16.7%
Q1 2022$2,055,000
-33.9%
1,568,597
-11.2%
0.01%
-14.3%
Q4 2021$3,109,000
-23.4%
1,766,277
-5.6%
0.01%
-22.2%
Q3 2021$4,059,000
-23.7%
1,870,697
+23.0%
0.01%
-25.0%
Q2 2021$5,323,000
-20.8%
1,520,734
+123.0%
0.01%
-29.4%
Q1 2021$6,724,000
-8.5%
681,934
+0.6%
0.02%
-19.0%
Q4 2020$7,346,000
-32.9%
677,630
-36.2%
0.02%
-46.2%
Q3 2020$10,947,000
+3342.5%
1,062,791
+6869.6%
0.04%
+1850.0%
Q2 2020$318,000
-48.6%
15,249
-86.6%
0.00%0.0%
Q3 2019$619,000
+57.9%
113,633
+52.1%
0.00%
+100.0%
Q1 2019$392,000
-54.4%
74,728
-72.6%
0.00%
-66.7%
Q4 2018$859,000
-23.4%
272,789
+47.2%
0.00%0.0%
Q3 2018$1,121,000
-43.0%
185,364
-50.0%
0.00%
-50.0%
Q2 2018$1,966,000
+1866.0%
370,959
+2053.9%
0.01%
Q1 2018$100,000
-91.5%
17,223
-94.9%
0.00%
-100.0%
Q4 2017$1,183,000
+331.8%
337,956
+350.5%
0.00%
+300.0%
Q3 2017$274,000
+75.6%
75,012
+20.4%
0.00%0.0%
Q2 2017$156,00062,3250.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q3 2021
NameSharesValueWeighting ↓
BML Capital Management, LLC 3,915,000$5,872,5005.39%
Versant Venture Management, LLC 5,068,233$7,602,3504.04%
Sonic GP LLC 2,000,000$3,000,0002.91%
COMMODORE CAPITAL LP 10,000,000$15,000,0001.75%
VR Adviser, LLC 6,573,300$9,859,9501.04%
AIGH Capital Management LLC 1,323,985$1,985,9770.94%
Newtyn Management, LLC 1,025,000$1,537,5000.38%
Worth Venture Partners, LLC 331,668$497,5020.30%
Acuitas Investments, LLC 291,169$436,7540.26%
Quinn Opportunity Partners LLC 398,298$597,4470.08%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders